Hi everyone
In a tertiary care hospital in Italy where I'm consultant in Infectious
Diseases, we had a small cluster of sepsis due to carbapenem-resistent
Klebsiella Pneumoniae (CRKP) , in all three cases they did US guided MW for the
treatment of HCC before the sepsis.
All the patients were treated with colistine plus amikacine ev (prooved
sensible) but they died in few days.
My question is: does the treatment of sepsis in this cases (excluded AB
therapy) differ in some ways to the common one? someone has experience?
In other words, waiting for new antibiotics (inshallah) can we improve the
survival in any way?
thanks
Maria Teresa Giordani, MD
Infectious and Tropical Diseases Unit
San Bortolo Hospital
Vicenza
Italy
_______________________________________________
Sepsisgroups mailing list
[email protected]
http://lists.sepsisgroups.org/listinfo.cgi/sepsisgroups-sepsisgroups.org
